PDCD1 and neoplasm: Glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) represents a potential immunotherapy target in various kinds of neoplasms (e.g., breast cancer, colorectal cancer), especially with concomitant use of PD-1 blockade [26].